ASTS · AST SpaceMobile, Inc. · Stock research

Current Thesis

Two events on 2026-07-15/16 removed the leg the June rebound stood on. AST SpaceMobile priced $1.0B of 1.625% convertible senior notes due 2034 at an initial conversion price of $79.57 a 20% premium to the prior $66.31 close with a capped call struck at $149.20, and in the same window pushed initial commercial direct-to-device service into early 2027. The stock closed 2026-07-16 at $55.01, down 17.0%, then bounced to roughly $58.45 on 7/17 after fading from +12.1% intraday. What remains is a fully funded balance sheet attached to a revenue start that has now moved twice since the 2026-05-28 New Glenn pad explosion. That is a different security than the one that rallied on the 6/17 BlueBird 8/9/10 orbit and the 6/23 Falcon 9 booking: the launch-access fix survived, the timeline did not. Sell-side responded by upgrading on price rather than on momentum Piper Sandler initiated Overweight with a $100 target on 7/16 while rating both SPCX and RKLB Neutral, and B. Riley's Mike Crawford moved to Buy at an $85 target on 7/17 citing risk/reward after a six-month drawdown exceeding 50%. Meanwhile ASTS was still a top-five most-discussed name on X and Reddit for the week of 7/13-7/17. Funded, delayed, crowded, and no longer trending: the useful stance is to let it build a higher low above the flush before treating any bounce as a new leg.

Bullish and bearish views on AST SpaceMobile, Inc.

The model's bull view on AST SpaceMobile, Inc. (ASTS), in brief: Financing risk is off the table (2026-07-16): $1.0B raised at 1.625% coupon with a capped call at $149.20 caps effective dilution well above spot; management no longer has to fund the constellation from a distressed share price. The bear view: Revenue start moved again (2026-07-16): initial commercial service guided to early 2027, with some coverage framing intermittent DTC service as a 2027-2028 event. Both cases follow in full.

Bull Case

• Financing risk is off the table (2026-07-16): $1.0B raised at 1.625% coupon with a capped call at $149.20 caps effective dilution well above spot; management no longer has to fund the constellation from a distressed share price. Shay Boloor's public argument that the ~1.5% effective dilution was misread is the mechanically correct reading of the structure.
• Analyst reset with real targets (2026-07-16/17): Piper Sandler's Overweight/$100 initiation named ASTS the preferred way into space versus a Neutral on SpaceX's listed vehicle and Rocket Lab; B. Riley's upgrade to Buy at $85 followed the next session. Two independent desks now carry targets 45-70% above the 7/17 close.
• Hardware is built and manifested (2026-07-01): BlueBirds 11-13 completed fabrication and hold a first-half-August Falcon 9 window, taking the in-orbit fleet to 13 vehicles. Execution on the 6/17 BlueBird 8/9/10 mission which doubled network data speeds is the counterweight to the schedule slippage.
• Regulatory catalyst dated and imminent (2026-07-22): the FCC votes on the Space Modernization Order, replacing Part 25 with a new Part 100, shrinking the public-notice window from 30 to 15 days and compressing licensing from over a year to weeks. Direct-to-device operators scaling constellations are the primary beneficiaries.
• Carrier book predates the wobble: AT&T, Verizon, Vodafone and the 2026-06-23/24 Rakuten agreement for Japan are demand commitments that do not reset on a launch-schedule slip.

Bear Case

• Revenue start moved again (2026-07-16): initial commercial service guided to early 2027, with some coverage framing intermittent DTC service as a 2027-2028 event. The original plan called for early service at end-2026 on at least 45 satellites; the August launch gets the fleet to 13.
• The tape rejected the raise (2026-07-16): a 17.0% single-day decline on financing news is the market pricing the raise as a signal about cost and timeline, not as balance-sheet hygiene. The 7/17 recovery gave back more than half its intraday gain by the close.
• Sector, not name, is the problem (2026-07-16): Rocket Lab fell on a Piper Neutral initiation into a sector-wide debt-dilution selloff, Firefly slid ~7% on rising short interest despite fresh NASA awards, and the listed SpaceX vehicle also drew a Neutral. The space complex is transitioning from accelerating to picked-over.
• Live short thesis (2026-06-12): Fugazi Research's "Lost In Space: A Narrative Launched On Hype" named ASTS first among six targets and remains unrebutted, which keeps two-way air pockets in the tape on any operational stumble.
• Peak-attention structure: top-five retail chatter ranking for the week of 7/13-7/17, leveraged single-stock ETF flow setting the intraday range, and a Cramer "Go For" endorsement on 7/2 that has since been followed by a 12% drawdown from the 7/15 close.
• SpaceX is a listed, capitalized competitor: the 6/12 IPO at roughly $2T valuation arms the dominant launch and Starlink direct-to-cell operator with acquisition currency in the same lane.

Setup & Price Structure

The 7/16 gap-down closed at $55.01, a level that sits above the June post-launch base but well below the $66.31 pre-announcement print. The 7/17 session produced a failed reclaim up 12.1% intraday, closing +5.1% near $58.45 which is the shape of dip-buying into supply rather than a base. Six-month performance is worse than -50%, so the multi-month structure is a downtrend with an intact lower-high sequence; the 6/17-to-7/2 rally never took out the spring highs. The $79.57 conversion price now functions as a soft overhead reference where convertible arbitrage hedging concentrates. A constructive re-set requires a higher low above the flush close and a daily reclaim of the pre-announcement $66 shelf on expanding volume; absent that, the August launch window is the next event that can force the issue. Chasing the bounce with a live short report and a delayed revenue start is the trap this structure is built to spring.

Catalyst Calendar (next 30 days)

• 2026-07-22 FCC open meeting votes on the Space Modernization Order (Part 25 → Part 100 licensing overhaul, 15-day public notice window). Sector-wide, dated, and the only hard catalyst inside two weeks.
• ~2026-08-01 to 2026-08-15 (est.) Falcon 9 launch window for BlueBirds 11-13; success takes the fleet to 13 vehicles and validates the launch-agnostic pivot. Another slip would be the third schedule failure since April.
• ~2026-08-10 (est.) Q2 2026 results. First management commentary on the raise, cash runway against the 2027 service date, and BlueBird-7 insurance recovery. Avoid fresh entries in the three trading days ahead of the print.
• Ongoing 8-K/424B filings around the convertible settlement and any capped-call mechanics; watch for a follow-on equity component, which the notes structure was supposed to make unnecessary.

What Would Change Our Mind

Upgrade the read if the August Falcon 9 window executes on schedule and management pairs the Q2 print with a firm, dated commercial-service start inside H1 2027 rather than a range that combination converts the raise from a distress signal into growth funding, and a daily reclaim of $66 on volume would confirm it. Add conviction if the 7/22 FCC order passes with direct-to-device provisions that shorten ASTS's own licensing path, and if the space complex re-broadens with RKLB and the listed SpaceX vehicle making higher highs alongside. Abandon the constructive case entirely on a weekly close below $52, on any further slip of the August launch window, or on a follow-on equity raise announced after a $1B convertible the last would mean the funding math presented on 7/15 was wrong.

Correlation Notes

ASTS trades as the highest-beta expression of the listed space complex and moved with the group on the 7/16 debt-dilution selloff that also hit RKLB and Firefly. Rocket Lab remains the cleaner operational comparison because it owns its launch vehicle; ASTS carries supplier risk that has now materialized twice. The 6/12 SpaceX listing turned the sector's largest private benchmark into a daily-marked competitor, so ASTS now correlates to SPCX sentiment as both a proxy and a share-loss candidate. Secondary correlations run to the telecom carriers underwriting the direct-to-device book and to Globalstar as the other listed satellite-to-phone operator. Leveraged single-stock ETF flow including the Defiance 2X product and the 31 single-stock leveraged funds launched 6/30 amplifies both directions and makes intraday range a poor read on institutional positioning.